Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Claudia Mulas is active.

Publication


Featured researches published by Claudia Mulas.


Journal of Alzheimer's Disease | 2009

Altered cholesterol ester cycle in skin fibroblasts from patients with Alzheimer's disease.

Alessandra Pani; Sandra Dessì; Giacomo Diaz; Paolo La Colla; Claudia Abete; Claudia Mulas; Fabrizio Angius; Maria Dolores Cannas; Christina Doriana Orru; Pier Luigi Cocco; Antonella Mandas; Paolo F. Putzu; Anna Laurenzana; Cristina Cellai; Antonio Mitidieri Costanza; A. Bavazzano; Alessandra Mocali; Francesco Paoletti

Intracellular cholesterol metabolism was reported to modulate amyloid-beta (Abeta) generation in Alzheimers disease (AD). Results presented herein demonstrated that, like brain cells, cultured skin fibroblasts from AD patients contained more cholesterol esters than fibroblasts from healthy subjects. Particularly, Oil Red-O, Nile Red, and filipin staining highlighted higher levels of neutral lipids which responded to inhibitors of acyl-coenzyme A:cholesterol acyl-transferase (ACAT-1), associated with an increase in free cholesterol. ACAT-1 mRNA levels increased significantly in AD fibroblasts, whereas those of sterol regulatory element binding protein-2, neutral cholesterol ester hydrolase, and ATP-binding cassette transporter member 1 were markedly down-regulated. Instead, mRNA levels of low-density lipoprotein receptor, hydroxy-methyl-glutaryl-coenzyme A reductase, caveolin-1, and amyloid-beta protein precursor (AbetaPP) were virtually unchanged. Notably, mRNA levels of both beta-site AbetaPP-cleaving enzyme 1 (BACE1) and neprilysin were significantly down-regulated. An increase in Abeta(40) and Abeta(42) immunostaining and a decrease in BACE1 active form were also found in AD versus control fibroblasts. Altogether, these findings support the hypothesis that the derangement of cholesterol homeostasis is a systemic alteration involving central but also peripheral cells of AD patients, and point to cholesterol ester levels in AD fibroblasts as an additional metabolic hallmark useful in the laboratory and clinical practice.


Antimicrobial Agents and Chemotherapy | 2007

Antiprion Activity of Cholesterol Esterification Modulators: a Comparative Study Using Ex Vivo Sheep Fibroblasts and Lymphocytes and Mouse Neuroblastoma Cell Lines

Alessandra Pani; Claudia Norfo; Claudia Abete; Claudia Mulas; Marirosa Putzolu; Sergio Laconi; Christina Doriana Orru; M. Dolores Cannas; Sarah Vascellari; Paolo La Colla; Sandra Dessì

ABSTRACT Our studies on the role of cholesterol homeostasis in the pathogenesis of scrapie revealed abnormal accumulation of cholesterol esters in ex vivo peripheral blood mononuclear cells (PBMCs) and skin fibroblasts from healthy and scrapie-affected sheep carrying a scrapie-susceptible genotype compared to sheep with a resistant genotype. Similar alterations were observed in mouse neuroblastoma N2a cell lines persistently infected with mouse-adapted 22L and RML strains of scrapie that showed up to threefold-higher cholesterol ester levels than parental N2a cells. We now report that proteinase K-resistant prion protein (PrPres)-producing cell populations of subclones from scrapie-infected cell lines were characterized by higher cholesterol ester levels than clone populations not producing PrPres. Treatments with a number of drugs known to interfere with different steps of cholesterol metabolism strongly reduced the accumulation of cholesterol esters in ex vivo PBMCs and skin fibroblasts from scrapie-affected sheep but had significantly less or no effect in their respective scrapie-resistant or uninfected counterparts. In scrapie-infected N2a cells, inhibition of cholesterol esters was associated with selective antiprion activity. Effective antiprion concentrations of cholesterol modulators (50% effective concentration [EC50] range, 1.4 to 40 μM) were comparable to those of antiprion reference compounds (EC50 range, 0.6 to 10 μM). These data confirm our hypothesis that abnormal accumulation of cholesterol esters may represent a biological marker of susceptibility to prion infection/replication and a novel molecular target of potential clinical importance.


Central European Journal of Biology | 2010

ACAT-1, Cav-1 and PrP expression in scrapie susceptible and resistant sheep

Cristina D. Orrù; Claudia Abete; M. Dolores Cannas; Claudia Mulas; Claudia Norfo; Antonella Mandas; Sarah Vascellari; Paolo La Colla; Sandra Dessì; Alessandra Pani

Scrapie is a prion disease for which no means of ante-mortem diagnosis is available. We recently found a relationship between cell susceptibility to scrapie and altered cholesterol homeostasis. In brains and in skin fibroblasts and peripheral blood mononuclear cells from healthy and scrapie-affected sheep carrying a scrapie-susceptible genotype, the levels of cholesterol esters were consistently higher than in tissues and cultures derived from animals with a scrapie-resistant genotype. Here we show that intracellular accumulation of cholesterol esters (CE) in fibroblasts derived from scrapie-susceptible sheep was accompanied by parallel alterations in the expression level of acyl-coenzymeA: cholesterol-acyltransferase (ACAT1) and caveolin-1 (Cav-1) that are involved in the pathways leading to intracellular cholesterol esterification and trafficking. Comparative analysis of cellular prion protein (PrPc) mRNA, showed an higher expression level in cells from animals carrying a susceptible genotype, with or without Scrapie. These data suggest that CE accumulation in peripheral cells, together with the altered expression of some proteins implicated in intracellular cholesterol homeostasis, might serve to identify a distinctive lipid metabolic profile associated with increased susceptibility to develop prion disease following infection.


Investigative Ophthalmology & Visual Science | 2007

Modulation of Cholesterol Homeostasis by Antiproliferative Drugs in Human Pterygium Fibroblasts

Enrico Peiretti; Sandra Dessì; Claudia Mulas; Claudia Abete; Claudia Norfo; Marirosa Putzolu; Maurizio Fossarello


Tumor Biology | 2012

A lipoprotein source of cholesteryl esters is essential for proliferation of CEM-CCRF lymphoblastic cell line

Sabrina Uda; S Accossu; Stefano Spolitu; Maria Collu; Fabrizio Angius; Francesca Sanna; Sebastiano Banni; C. Vacca; Elisabetta Murru; Claudia Mulas; Giacomo Diaz; Barbara Batetta


American Journal of Infectious Diseases | 2007

Cholesterol Metabolism in Brain and Skin Fibroblasts from Sarda Breed Sheep With Scrapie-resistant and Scrapie-susceptible Genotypes

Alessandra Pani; Claudia Abete; Claudia Norfo; Claudia Mulas; Marirosa Putzolu; Sergio Laconi; M. Dolores Cannas; Cristina D. Orrù; Paolo La Colla; Sandra Dessì


American Journal of Infectious Diseases | 2007

Accumulation of cholesterol esters in ex vivo lymphocytes from scrapie-susceptible sheep and in scrapie-infected mouse neuroblastoma cell lines

Alessandra Pani; Claudia Norfo; Claudia Abete; Claudia Mulas; Marirosa Putzolu; Sergio Laconi; Christina Doriana Orru; M. Dolores Cannas; Sarah Vascellari; Paolo La Colla; Sandra Dessì


Nature Precedings | 2007

Changes in Cholesterol Metabolism in Peripheral Cells of Alzheimer Disease Patients and Their Relatives

Alessandra Pani; Paolo La Colla; Claudia Abete; Claudia Mulas; Marirosa Putzolu; Claudia Norfo; Sergio Laconi; Anna Borgia; Christina Zaru; Manuela Palmas; Paolo F. Putzu; Alessandra Mocali; Francesco Paoletti; Sandra Dessì


Nature Precedings | 2007

ACAT1, Cav-1, and PrP expression in brains and skin fibroblasts from Sarda breed sheep with scrapie-resistant and scrapie-susceptible genotype.

Alessandra Pani; Marirosa Putzolu; Claudia Mulas; Cristina D. Orrù; Claudia Abete; Claudia Norfo; M. Dolores Cannas; Sergio Laconi; Paolo La Colla; Sandra Dessì


Nature Precedings | 2008

Altered cholesterol ester cycle in ex vivo skin fibroblasts from Alzheimer patients

Alessandra Pani; Sandra Dessì; Giacomo Diaz; Claudia Abete; Claudia Mulas; Claudia Norfo; Marirosa Putzolu; Maria Dolores Cannas; Christina Doriana Orru; Alessandra Mocali; Pier Luigi Cocco; Paolo La Colla; Francesco Paoletti

Collaboration


Dive into the Claudia Mulas's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge